cardiovalve - About the company
cardiovalve is an acquired company based in Or Yehuda (Israel), founded in 2011. It operates as a Developer of a novel transcatheter valve replacement system for mitral and tricuspid valve replacement. This system is designed for transfemoral delivery, avoiding open-heart surgery. Key features include a short profile to minimize ventricular protrusion and reduce LVOT obstruction risk, a robust anchoring mechanism, and an enhanced sealing solution to prevent paravalvular leaks. The device is currently limited to investigational use.. The company has 109 active competitors, including 49 funded and 28 that have exited. Its top competitors include companies like Shockwave Medical, Cardiac Dimensions and MicroPort CardioFlow Medtech Corporation.
Key Metrics
Founded Year
2011
Location
Or Yehuda, Israel
Stage
Acquired
Investors
Ranked
17th among 109 active competitors
Employee Count
47 as on Aug 31, 2026
Similar Companies
Exit Details
Acquired by Venus MedTech (Dec 07, 2021)
cardiovalve's acquisition details
cardiovalve got acquired by Venus MedTech on Dec 07, 2021 at an acquisition amount of $*****.
Click here to take a look at cardiovalve's acquisition in detail
Sign up to download cardiovalve's company profile
cardiovalve's funding and investors
cardiovalve is a funded company. cardiovalve has 3 institutional investors.
View details of cardiovalve's funding rounds and investors
cardiovalve's founders and board of directors
Founder? Claim Profilecardiovalve's employee count trend
cardiovalve has 47 employees as of Aug 26. Here is cardiovalve's employee count trend over the years:
Uncover cardiovalve's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
cardiovalve's Competitors and alternates
Top competitors of cardiovalve include Shockwave Medical, Cardiac Dimensions and MicroPort CardioFlow Medtech Corporation. Here is the list of Top 10 competitors of cardiovalve, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Shockwave Medical 2009, Santa Clara (United States), Acquired | Developer of cardiovascular balloon dilation catheters | $148M | 65/100 | |
2nd | Cardiac Dimensions 2001, Kirkland (United States), Series E | Developer of invasive cardiac implants for heart failure | $261M | 63/100 | |
3rd |  MicroPort CardioFlow Medtech Corporation 2015, Pudong (China), Public | Developer of smart medical devices for patients with heart valve diseases | $132M | 63/100 | |
4th | Peijia Medical Technologies 2012, Suzhou (China), Public | Developer of medical devices for the treatment of cardiac and cerebrovascular diseases | $110M | 63/100 | |
5th | JenaValve Technology 2006, Irvine (United States), Acquired | Provider of pericardial transcatheter aortic valve replacement and delivery system | $364M | 62/100 | |
6th | Venus MedTech 2009, Hangzhou (China), Public | Transcatheter aortic valves | $37M | 61/100 | |
7th | Developer of a percutaneous device for treating tricuspid regurgitation | $52.1M | 58/100 | ||
8th | Developer of a minimally invasive tricuspid valve replacement system. This system is designed to treat tricuspid regurgitation, a serious heart condition, without the need for open-heart surgery. The company focuses on developing a safe and effective solution to address the limitations of existing treatment approaches. It is developing a catheter-based system for tricuspid valve replacement. The company's efforts include clinical trials and securing funding to support further development and clinical milestones. | $103M | 57/100 | ||
9th |  Foldax 2006, Salt Lake City (United States), Series D | Developer of bio-polymeric heart valves to treat aortic, mitral, and tricuspid valve diseases | $43.7M | 56/100 | |
10th |  HighLife Medical 2010, Paris (France), Series B | Developer of trans-catheter mitral valve replacement system | $50.8M | 56/100 | |
17th |  cardiovalve 2011, Or Yehuda (Israel), Acquired | Developer of a novel transcatheter valve replacement system for mitral and tricuspid valve replacement. This system is designed for transfemoral delivery, avoiding open-heart surgery. Key features include a short profile to minimize ventricular protrusion and reduce LVOT obstruction risk, a robust anchoring mechanism, and an enhanced sealing solution to prevent paravalvular leaks. The device is currently limited to investigational use. | - | 50/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on cardiovalve's competitors? Click here to see the top ones
cardiovalve's Investments and acquisitions
cardiovalve has made no investments or acquisitions yet.
News related to cardiovalve
Media has covered cardiovalve for a total of 2 events in the last 1 year.
•
Cardiovalve Submits CE File for Approval After Successful TARGET Study CompletionEuropa Press•Nov 17, 2025•cardiovalve
•
•
Venus Medtech Concludes Acquisition of 100% Equity Interest in CardiovalvePR Newswire•Jan 25, 2022•Venus MedTech, cardiovalve
•
•
Transcatheter Tricuspid Valve Replacement System Gains Breakthrough StatusMedical Product Outsourcing•Apr 17, 2020•cardiovalve
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about cardiovalve
Explore our recently published companies
- Qvet - 2016 founded, Unfunded company
- eLearning Solutions Lab - Philippines based, 2026 founded, Unfunded company
- Sentiense - India based, 2026 founded, Unfunded company
- Shema Wearable Art - Hyderabad based, 2026 founded, Unfunded company
- Bliblio - France based, 2026 founded, Unfunded company
- BARNES Buenos Aires - 2026 founded, Unfunded company
